Cerebral infarction is a common acute cerebrovascular disease in clinical practice, characterized by high disability rate, high mortality rate and high morbidity. Patients with acute cerebral infarction who fail to obtain effective treatment may experience symptoms of impaired cerebral neurological function, which may seriously lead to disability, thus seriously affecting the quality of life of patients. The following four drugs are commonly used for cerebral infarction treatment: 1. Anticoagulants: such as Ozagrel, which inhibit deterioration or improve prognosis through the anticoagulant effect of the drug. Combined use of Ozagrel and Ginkgo Biloba for acute cerebral infarction can achieve good results; 2. Anti-platelet aggregation drugs: commonly used anti-platelet aggregation agents include aspirin and clopidogrel, which can be used in combination with butylphthalein soft capsules, which have a protective effect against ischemic brain injury; 3. Statins: i.e., reductase inhibitors, which inhibit endogenous cholesterol synthesis by inhibiting atherosclerosis and 3, statins: i.e. reductase inhibitors, which inhibit atherosclerosis and thrombosis by inhibiting endogenous cholesterol synthesis and protect the endothelium of blood vessels. Drugs such as vitamin B1 and cytarabine can nourish nerves, protect brain cells, protect damaged nerves from ischemia and hypoxia, and relieve the symptoms of cerebral infarction. In addition, dehydration cranial pressure lowering drugs, circulation improvement drugs and blood pressure lowering drugs also have certain therapeutic effects on cerebral infarction. Patients with different conditions should seek medical advice before choosing the right drugs for themselves.